TNF Pharmaceuticals, Inc. (TNFA)

TNF Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.07	0.17	2.68	0.75	0.56	0.15
Short-Term Investments	5.81	8.35	2.24	4.09	11	-
Cash & Short-Term Investments	5.88	8.52	4.92	4.84	11.56	0.15
Cash Growth	238.82%	73.02%	1.80%	-58.16%	7695.20%	12.32%
Prepaid Expenses	0.9	0.89	0.89	0.57	1.11	0
Total Current Assets	6.78	9.41	5.82	5.4	12.67	0.15
Property, Plant & Equipment	0	0.01	0.05	0.14	0.15	0.53
Long-Term Investments	1.5	1.5	1.5	1.5	1.5	-
Goodwill	10.5	10.5	10.5	10.5	10.5	-
Total Assets	18.78	21.42	17.86	17.54	24.81	0.68
Accounts Payable	2.59	2.52	3.08	2.36	0.87	1.1
Accrued Expenses	-	0.39	0.64	0.32	0.12	0.7
Short-Term Debt	-	-	-	-	-	0.07
Current Portion of Leases	0	0.01	0.05	0.07	0.05	0.48
Other Current Liabilities	2.34	3.79	1.22	0.03	-	-
Total Current Liabilities	4.94	6.7	4.99	2.77	1.04	2.35
Long-Term Debt	-	-	-	-	-	3.53
Long-Term Leases	-	-	-	0.08	0.1	0.05
Other Long-Term Liabilities	-	-	0.1	-	0.03	-
Total Liabilities	4.94	6.7	5.09	2.84	1.17	5.93
Common Stock	0.01	0	0	0	102.06	0
Additional Paid-In Capital	139.62	138.78	114.2	108.31	-	43.41
Retained Earnings	-131.08	-129.14	-101.98	-93.76	-78.56	-48.67
Total Common Equity	8.55	9.65	12.23	14.55	23.5	-5.26
Shareholders' Equity	13.84	14.72	12.77	14.7	23.65	-5.26
Total Liabilities & Equity	18.78	21.42	17.86	17.54	24.81	0.68
Total Debt	0	0.01	0.05	0.14	0.15	4.13
Net Cash (Debt)	5.88	8.51	4.87	4.69	11.41	-3.98
Net Cash Growth	245.84%	74.54%	3.83%	-58.86%	-	-
Net Cash Per Share	1.81	3.49	3.16	3.63	9.78	-4.24
Filing Date Shares Outstanding	14.18	10.13	2.16	1.32	1.27	1.34
Total Common Shares Outstanding	3.36	3.36	2.02	1.32	1.26	1.34
Working Capital	1.84	2.71	0.83	2.63	11.63	-2.2
Book Value Per Share	2.54	2.87	6.06	11.06	18.72	-3.94
Tangible Book Value	-1.95	-0.85	1.73	4.05	13	-5.26
Tangible Book Value Per Share	-0.58	-0.25	0.86	3.08	10.36	-3.94

Updated Apr 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q